Effect of Metformin Treatment on some Blood Biomarkers in Women with Endometriosis.

Noor A.Omer, Maryam Taher, Henan Dh Skheel Aljebory
In: Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512) · 2017 · vol. 25(1) , pp. 28–36 · doi:10.31351/vol25iss1pp28-36 · W2582913982
article OA: diamond CC0 ⤵ 3 in-corpus citations
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

Metformin treatment for three months significantly reduced pelvic pain, dysmenorrhea, and serum levels of IL-8 and TNF-α in women with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-07 ⓘ

This study evaluated whether metformin treatment for three months affected serum inflammatory biomarkers (IL-8 and TNF-α) and estradiol (E2), alongside symptom changes (pelvic pain, dysmenorrhea, and menorrhagia) in women with endometriosis, using pre- versus post-treatment blood measurements and symptom assessment in the metformin-treated group. After three months, metformin significantly reduced clinical symptoms of pelvic pain and dysmenorrhea, while menorrhagia showed insignificant change. Serum IL-8 and TNF-α levels also decreased significantly, whereas estradiol E2 exhibited only an insignificant reduction. The paper’s main caveat, as presented, is its limited follow-up duration of three months. This paper is centrally about endometriosis — it tests metformin’s effects on inflammatory biomarkers and reproductive hormones in relation to pelvic pain and menstrual symptoms.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis is a common women health disorder that occurs when Endometrial-like tissue grows outside the uterus. This may lead to irregular bleeding , pelvic pain, infertility and other complications. Metformin, because of its activity to improve insulin sensitivity, it is used for the treatment of diabetes; it also has a modulatory effect on ovarian steroid production and has anti-inflammatory properties, all may suggest its possible effect in treatment of endometriosis. This study was planned to determine the effect of metformin on serum levels of interleukin- eight(IL-8), Tumor necrosis factor-alpha (TNF –α) and estradiol (E2) production , and related symptomatic changes that accompany with endometriosis (pelvic pain, dysmenorrhea and menorrheaga) after three months of study. Blood samples were obtained from those taking metformin and measure the serum levels of (IL-8) , TNF –α and (E2) were measured before and after three months of taking a metformin .Metformin therapy resulted in a significant reduction in the clinical symptoms of endometriosis (pelvic pain and dysmenorrhea) and insignificant changes in menorrhagia. Metformin therapy resulted in a significant reduction in the serum levels of IL-8, TNF- α while insignificant reduction in estradiol E 2 in the study group after 3 months of treatment .In conclusion the results of this study, demonstrated that metformin may be a well-tolerated treatment for endometriosis that relieved pain and reduces menstrual disorders and serum levels of the inflammatory markers (IL-8 and TNF-α) are decreased in study group treated with metformin after 3 months due to its anti- inflammatory effects. Keywords: Endometriosis, Metformin, TNF – a ,IL-8, E 2.

My notes (saved in your browser only)

Condition tags

endometriosisdysmenorrheainfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (19)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK